Sclerosis multiplex (SM): vizsgálatok itt: Ukrajna

In Ukrajna 5 Also abroad 506

5 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

3. fázisTaking people
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Where
Chernivtsi, Ivano-Frankivsk, Lviv, Vinnytsia
Életkor
18 év to 60 év
People
705 worldwide
Run by
Zenas BioPharma (USA), LLC
See details and how to joinNCT07067463 · EU 2025-524316-11-00
2. fázisTaking people
A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)
Where
Lviv
Életkor
10 év to 17 év
People
12 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07161258 · EU 2024-519800-28-00
3. fázisTaking people
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Where
Chernivtsi, Ivano-Frankivsk, Lviv, Vinnytsia
Életkor
18 év to 60 év
People
990 worldwide
Run by
Zenas BioPharma (USA), LLC
See details and how to joinNCT07299019 · EU 2025-524322-18-00
2. fázisTaking people
A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative Bioavailability Via Autoinjector (AI) Versus Syringe Subcutaneously in Participants With Multiple Sclerosis (MS)
Where
Chernihiv, Ivano-Frankivsk, Kyiv, Lviv, Odesa, Poltava, Ternopil, Uzhhorod, Vinnytsia
Életkor
18 év to 65 év
People
350 worldwide
Run by
TG Therapeutics, Inc.
See details and how to joinNCT07503873 · EU 2025-523757-33-00
3. fázisTaking people
An Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function and Provide Continued Ocrelizumab Treatment
Where
Cherkasy, Chernihiv, Chernivtsi, Dnipro, Ivano-Frankivsk, Kharkiv, Kyiv, Lutsk, Lviv, Vinnytsi, Zaporizhzhya
Életkor
18 év and over
People
500 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06675955 · EU 2023-507633-21-01